Vault-13

First Turn Management, LLC

DEL MAR, CA · CIK 1993440 · 13F filing filed 2025-08-14

SEC-registered investment adviser since 2023 · limited liability company

$536.0m reported value +8.1% vs Q1 2025
35positions
46.7%in top 10
7 new 14 added 14 reduced 7 sold out vs Q1 2025

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 INSMED INC COM PAR $.01 INSM INSM 372,672 $37.5m7.00% 7.00% ReducedShares held: Q3 2024 356.5k, Q4 2024 447.0k, Q1 2025 401.6k, Q2 2025 372.7k -29.0k -28,957 -7.2%
2 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 309,988 $29.3m5.47% 5.47% ReducedShares held: Q3 2024 572.9k, Q4 2024 641.9k, Q1 2025 435.4k, Q2 2025 310.0k -125.4k -125,397 -28.8%
3 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 527,540 $26.8m5.01% 5.01% AddedShares held: Q3 2024 647.6k, Q4 2024 506.9k, Q1 2025 503.0k, Q2 2025 527.5k +24.5k +24,526 4.9%
4 NUVALENT INC COM COM 320,798 $24.5m4.57% 4.57% ReducedShares held: Q3 2024 359.1k, Q4 2024 309.5k, Q1 2025 331.9k, Q2 2025 320.8k -11.1k -11,129 -3.4%
5 ARGENX SE SPONSORED ADR ARGX ARGX 43,953 $24.2m4.52% 4.52% AddedShares held: Q3 2024 54.4k, Q4 2024 43.1k, Q1 2025 41.9k, Q2 2025 44.0k +2.0k +2,042 4.9%
6 BRIDGEBIO PHARMA INC COM BBIO BBIO 551,684 $23.8m4.44% 4.44% ReducedShares held: Q3 2024 399.8k, Q4 2024 452.3k, Q1 2025 656.7k, Q2 2025 551.7k -105.0k -105,015 -16.0%
7 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 134,687 $23.2m4.34% 4.34% AddedShares held: Q3 2024 150.6k, Q4 2024 87.8k, Q1 2025 113.3k, Q2 2025 134.7k +21.4k +21,409 18.9%
8 XENON PHARMACEUTICALS INC COM XENE XENE 660,617 $20.7m3.86% 3.86% ReducedShares held: Q3 2024 325.2k, Q4 2024 685.0k, Q1 2025 683.5k, Q2 2025 660.6k -22.8k -22,834 -3.3%
9 ORIC PHARMACEUTICALS INC COM ORIC ORIC 2,009,923 $20.4m3.81% 3.81% ReducedShares held: Q3 2024 1.5m, Q4 2024 1.5m, Q1 2025 2.0m, Q2 2025 2.0m -17.5k -17,507 -0.9%
10 NATERA INC COM NTRA NTRA 118,130 $20.0m3.72% 3.72% ReducedShares held: Q3 2024 155.7k, Q4 2024 99.2k, Q1 2025 139.9k, Q2 2025 118.1k -21.8k -21,812 -15.6%
11 ADMA BIOLOGICS INC COM ADMA ADMA 1,092,361 $19.9m3.71% 3.71% AddedShares held: Q3 2024 665.0k, Q4 2024 684.2k, Q1 2025 566.9k, Q2 2025 1.1m +525.4k +525,416 92.7%
12 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 32,305 $17.6m3.27% 3.27% AddedShares held: Q3 2024 30.3k, Q4 2024 35.0k, Q1 2025 22.1k, Q2 2025 32.3k +10.2k +10,196 46.1%
13 INSULET CORP COM PODD PODD 51,408 $16.2m3.01% 3.01% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 49.4k, Q2 2025 51.4k +2.1k +2,058 4.2%
14 TG THERAPEUTICS INC COM TGTX TGTX 447,884 $16.1m3.01% 3.01% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 400.6k, Q2 2025 447.9k +47.2k +47,240 11.8%
15 DISC MEDICINE INC COM IRON IRON 299,464 $15.9m2.96% 2.96% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 299.5k
16 GUARDANT HEALTH INC COM GH GH 302,307 $15.7m2.93% 2.93% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 315.7k, Q2 2025 302.3k -13.4k -13,430 -4.2%
17 MERUS N V COM MRUS MRUS 292,964 $15.4m2.87% 2.87% ReducedShares held: Q3 2024 308.0k, Q4 2024 285.2k, Q1 2025 464.0k, Q2 2025 293.0k -171.0k -170,996 -36.9%
18 REVOLUTION MEDICINES INC COM RVMD RVMD 415,591 $15.3m2.85% 2.85% AddedShares held: Q3 2024 0, Q4 2024 403.9k, Q1 2025 340.1k, Q2 2025 415.6k +75.5k +75,482 22.2%
19 AXSOME THERAPEUTICS INC COM AXSM AXSM 144,400 $15.1m2.81% 2.81% AddedShares held: Q3 2024 255.3k, Q4 2024 192.1k, Q1 2025 118.2k, Q2 2025 144.4k +26.2k +26,221 22.2%
20 BOSTON SCIENTIFIC CORP COM BSX BSX 138,834 $14.9m2.78% 2.78% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 178.2k, Q2 2025 138.8k -39.3k -39,322 -22.1%
21 ARCELLX INC COMMON STOCK ACLX ACLX 215,223 $14.2m2.64% 2.64% NewShares held: Q3 2024 214.3k, Q4 2024 152.4k, Q1 2025 0, Q2 2025 215.2k
22 APOGEE THERAPEUTICS INC COM COM 311,490 $13.5m2.52% 2.52% AddedShares held: Q3 2024 0, Q4 2024 252.7k, Q1 2025 229.7k, Q2 2025 311.5k +81.8k +81,815 35.6%
23 RADNET INC COM RDNT RDNT 197,759 $11.3m2.10% 2.10% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 157.6k, Q2 2025 197.8k +40.1k +40,144 25.5%
24 JANUX THERAPEUTICS INC COM JANX JANX 447,420 $10.3m1.93% 1.93% AddedShares held: Q3 2024 0, Q4 2024 383.6k, Q1 2025 430.2k, Q2 2025 447.4k +17.3k +17,257 4.0%
25 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 509,987 $10.2m1.91% 1.91% ReducedShares held: Q3 2024 535.1k, Q4 2024 535.1k, Q1 2025 535.1k, Q2 2025 510.0k -25.1k -25,105 -4.7%
26 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 521,097 $9.4m1.76% 1.76% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 521.1k
27 HEALTHEQUITY INC COM HQY HQY 80,880 $8.5m1.58% 1.58% ReducedShares held: Q3 2024 0, Q4 2024 125.9k, Q1 2025 84.0k, Q2 2025 80.9k -3.1k -3,086 -3.7%
28 ARS PHARMACEUTICALS INC COM SPRY SPRY 455,953 $8.0m1.48% 1.48% ReducedShares held: Q3 2024 593.3k, Q4 2024 593.3k, Q1 2025 669.0k, Q2 2025 456.0k -213.1k -213,057 -31.9%
29 VERA THERAPEUTICS INC CL A VERA VERA 309,666 $7.3m1.36% 1.36% ReducedShares held: Q3 2024 326.5k, Q4 2024 464.8k, Q1 2025 623.6k, Q2 2025 309.7k -313.9k -313,946 -50.3%
30 SOLENO THERAPEUTICS INC COM SLNO SLNO 86,332 $7.2m1.35% 1.35% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 29.1k, Q2 2025 86.3k +57.2k +57,217 196.5%
31 HARROW INC COM HROW HROW 228,761 $7.0m1.30% 1.30% AddedShares held: Q3 2024 326.6k, Q4 2024 304.9k, Q1 2025 188.8k, Q2 2025 228.8k +39.9k +39,932 21.1%
32 AKERO THERAPEUTICS INC COM AKRO AKRO 114,554 $6.1m1.14% 1.14% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 114.6k
33 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 17,879 $5.8m1.09% 1.09% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 17.9k
34 KALVISTA PHARMACEUTICALS INC COM KALV KALV 214,138 $2.4m0.45% 0.45% NewShares held: Q3 2024 355.0k, Q4 2024 0, Q1 2025 0, Q2 2025 214.1k
35 BETA BIONICS INC COM BBNX BBNX 157,194 $2.3m0.43% 0.43% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 157.2k

Sold out since Q1 2025

SecurityTickerShares held beforeValue then
SPRINGWORKS THERAPEUTICS INC SWTX SWTX 304,076 $13.4m304.1k shares
GLAUKOS CORP GKOS GKOS 136,241 $13.4m136.2k shares
EXACT SCIENCES CORP EXAS EXAS 300,909 $13.0m300.9k shares
VAXCYTE INC PCVX PCVX 276,905 $10.5m276.9k shares
BLUEPRINT MEDICINES CORP BPMC BPMC 92,033 $8.1m92.0k shares
MOONLAKE IMMUNOTHERAPEUTICS MLTX MLTX 179,196 $7.0m179.2k shares
PRAXIS PRECISION MEDICINES I PRAX PRAX 71,775 $2.7m71.8k shares